Blood cancer, a broad category encompassing over 140 distinct conditions, is increasingly being diagnosed in younger adults, a trend that defies previous understandings of the disease as primarily affecting older populations. The issue gained public attention following the death of actor Sam Neill from a rare, aggressive form of non-Hodgkin lymphoma.

While advancements in diagnostic testing have improved case detection, experts like Professor Dan Landau from Weill Cornell Medicine suggest this alone does not explain the rise. He points to potential contributing factors including obesity, chronic inflammation, environmental exposures, and changes in the immune system. These factors may create an environment conducive to cancer development.

Shifting Demographics and Specific Cancers

Historically, blood cancers like leukemia, lymphoma, and multiple myeloma were more commonly associated with older age groups. However, specific aggressive forms are showing concerning increases among teenagers and young adults. While overall rates of non-Hodgkin lymphoma have slightly declined, this masks a worrying trend of rising diagnoses in younger demographics, even as rates fall in older adults.

Cancers such as Burkitt lymphoma, known for its rapid growth, and acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) have demonstrated notable increases in younger age groups. Between 1990 and 2021, the number of Americans living with Burkitt lymphoma more than tripled, with deaths also doubling. Similarly, AML diagnoses and deaths have steadily climbed among young adults.

Suspected Drivers of the Increase

Obesity is emerging as a significant suspect, with excess weight contributing to chronic inflammation and altering immune system function, thereby creating a more favorable environment for cancer. Deaths linked to obesity from certain blood cancers have more than doubled since 1990, with the United States experiencing a notable impact.

Smoking remains a conclusively linked lifestyle factor, particularly for AML. Chemicals in cigarette smoke, such as benzene, can damage DNA in blood-producing cells in the bone marrow.

Environmental factors are also under scrutiny. Per- and polyfluoroalkyl substances (PFAS), or "forever chemicals," used in various consumer products, are being investigated. Studies have shown higher rates of some blood cancers, including non-Hodgkin lymphoma, among firefighters and workers with high occupational exposure to PFAS. The risk to the general population from lower-level exposure remains unclear.

Pesticides are another area of concern, with research linking agricultural pesticide exposure to an increased risk of non-Hodgkin lymphoma, particularly among those with direct occupational exposure. The impact of lower-level exposure through food residues or environmental contamination is less clear.

Air pollution, specifically fine particulate matter (PM2.5), is also being examined. These particles can enter the bloodstream and may trigger chronic inflammation and DNA damage, potentially contributing to cancer development, though direct causal links to blood cancers are not yet firmly established.

Experts hypothesize that chronic inflammation, whether stemming from obesity, autoimmune diseases, or pollutant exposure, may be a common thread linking these risks. Persistent inflammation can keep the immune system overactive, potentially allowing cancerous cells to thrive.

Minimizing Risk

While there is no guaranteed prevention, experts recommend several steps to reduce risk. Avoiding smoking is paramount. Maintaining a healthy weight is also crucial, as obesity is an established, modifiable risk factor for several blood cancers.

Reducing exposure to harmful chemicals, particularly in the workplace, is advised. Understanding family health history is important, as some blood cancers have a familial component, warranting discussions with a doctor for those with a family history.

Finally, individuals are urged not to ignore persistent symptoms such as fatigue, swollen lymph nodes, unexplained bruising, recurrent infections, or night sweats. Prompt medical evaluation for any concerning, ongoing symptoms is essential, as early detection can significantly impact outcomes.